Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale
about
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic reviewGuanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral painThe quest for biomarkers in IBS-where should it lead us?Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind studyCharacterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire.The Experience Sampling Method--a new digital tool for momentary symptom assessment in IBS: an exploratory study.Virtual Reality for Management of Pain in Hospitalized Patients: Results of a Controlled Trial.'Gut health': a new objective in medicine?Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials.Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.Understanding gastrointestinal distress: a framework for clinical practice.Catastrophizing: a predictor of persistent pain among women with endometriosis at 1 year.Change in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort StudyA 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationRandomised controlled trial of mesalazine in IBS.Development and Validation of a Questionnaire to Measure Serious and Common Quality of Life Issues for Patients Experiencing Small Bowel Obstructions.The brain-gut axis in abdominal pain syndromes.Dependence of the minimal clinically important improvement on the baseline value is a consequence of floor and ceiling effects and not different expectations by patients.Technical report: an ePRO patient reported outcome program for the evaluation of patients with irritable bowel syndrome.SIM BRASIL STUDY - WOMEN'S GASTROINTESTINAL HEALTH: GASTROINTESTINAL SYMPTOMS AND IMPACT ON THE BRAZILIAN WOMEN QUALITY OF LIFE.Systematic review: instruments to assess abdominal pain in irritable bowel syndrome.Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study.Asymmetries in reciprocal baroreflex mechanisms and chronic pain severity: Focusing on irritable bowel syndrome.Emergency department burden of constipation in the United States from 2006 to 2011.Single-day sodium picosulfate and magnesium citrate versus split-dose polyethylene glycol for bowel cleansing prior to colonoscopy: A prospective randomized endoscopist-blinded trial.Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia.Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation
P2860
Q26824003-B116FB90-7945-4FC0-AD07-AA3F99042ABFQ26863234-DEFBCF4F-F894-470E-9711-0EF0492D4614Q27024239-BB17DF13-23FF-448C-ADBC-76E3BB1BB848Q28239840-2FF85B0D-4D33-4002-9C0E-EBA0B068A12BQ30433548-DB891899-EFE4-46AA-88BC-8719BAB7CC04Q33462226-530041AB-89DE-4835-9A4A-619BC4EEAFF0Q33465409-0E78C58E-4078-4597-86BD-54F64FB52645Q33559672-C917E867-27FA-4890-9434-5F2FF6E4329EQ33845395-C9A36AB7-234B-4EDF-BD58-4DFD32590B42Q34165218-11BE501C-C6C6-4647-8DCA-6A087ADFBBA8Q34577699-D91A193F-9D97-4EC6-AF9E-3333041EB120Q34764154-6FA09302-163C-43EB-BFA8-C2777C459991Q34764170-F9DACC94-7B2D-480B-9362-6879EC51E3FFQ35389246-9891A8F2-454C-4F6E-A74F-69AB3D4615B6Q35797307-F8087C2E-233A-4447-8265-53CFAEA4E260Q36417684-1BC5682D-0964-4010-ABDE-1B3D7D07C952Q36475502-BAAB7EB7-548C-4A26-859E-ABD8C198529EQ37069237-816D7971-E6C9-43E3-8BF0-96A75015F08EQ37280260-C6CDB2C3-973B-4817-B4C7-3649840EFA4AQ37732454-11BDC182-019F-4456-A11E-4AF8A0092A5EQ38172579-A410391B-E896-40BB-954B-4652ACC56C16Q38379748-6C24ACE1-1456-4B54-8BDA-AB39D910A99FQ38569948-86D76219-26F6-4BD9-857B-C545679B49E7Q39187715-62EED4BE-BC59-4E4F-B8E8-481DA6DBAF92Q39311712-98BF3AA0-6C0F-41E6-A436-24F7637242D7Q41171717-A5DAFA6A-4EE5-4B7F-B129-D1D8BBD26AFBQ41742003-32D1B71A-C8EF-4B8F-AD1B-EC3F3FA389C3Q43200471-3221A660-16B3-4442-9D45-B40081A857FEQ51310014-6B76542F-F679-4AB2-9073-C41F4DA8585EQ55063629-88896E52-109C-426F-85F3-AC2E39CFBE6FQ57298241-AAED949B-2684-49F8-9108-8CEEBB8FDD1F
P2860
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Measuring irritable bowel synd ...... inal pain numeric rating scale
@en
Measuring irritable bowel synd ...... nal pain numeric rating scale.
@nl
type
label
Measuring irritable bowel synd ...... inal pain numeric rating scale
@en
Measuring irritable bowel synd ...... nal pain numeric rating scale.
@nl
prefLabel
Measuring irritable bowel synd ...... inal pain numeric rating scale
@en
Measuring irritable bowel synd ...... nal pain numeric rating scale.
@nl
P2093
P2860
P1476
Measuring irritable bowel synd ...... inal pain numeric rating scale
@en
P2093
B Naliboff
E Esrailian
K Tillisch
L A Harris
P2860
P304
P356
10.1111/J.1365-2036.2009.04144.X
P407
P577
2009-09-12T00:00:00Z